SHIFT Newsroom · GLOBAL
Trial record: CagriSema versus tirzepatide in type 2 diabetes
Registry status checked on 3 October 2026: completed.
ClinicalTrials.gov lists NCT06534411, concerning CagriSema versus tirzepatide in type 2 diabetes, as completed. The record was first posted on 2024-08-02 and last updated on 2026-09-09; SHIFT checked it on 3 October 2026. The recorded study-completion date is 2026-07-09.
The registration describes a research question and protocol, not proof that the intervention is effective or suitable for an individual.
No results tables were posted in this registry record when checked. That does not establish that no results have been published elsewhere. A registry entry is not a UK marketing authorisation or confirmation of NHS access.
SHIFT’s take
Keep the trial status, published results and UK treatment access separate. Do not change treatment on the basis of a registration.